Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-26539
Nowak, E C; Weaver, C T; Turner, H; Begum-Haque, S; Becher, B; Schreiner, B; Coyle, A J; Kasper, L H; Noelle, R J (2009). IL-9 as a mediator of Th17-driven inflammatory disease. Journal of Experimental Medicine, 206(8):1653-1660.
|PDF (Epub ahead of print version)|
We report that like other T cells cultured in the presence of transforming growth factor (TGF) beta, Th17 cells also produce interleukin (IL) 9. Th17 cells generated in vitro with IL-6 and TGF-beta as well as purified ex vivo Th17 cells both produced IL-9. To determine if IL-9 has functional consequences in Th17-mediated inflammatory disease, we evaluated the role of IL-9 in the development and progression of experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis. The data show that IL-9 neutralization and IL-9 receptor deficiency attenuates disease, and this correlates with decreases in Th17 cells and IL-6-producing macrophages in the central nervous system, as well as mast cell numbers in the regional lymph nodes. Collectively, these data implicate IL-9 as a Th17-derived cytokine that can contribute to inflammatory disease.
|Item Type:||Journal Article, refereed, original work|
|Communities & Collections:||04 Faculty of Medicine > Psychiatric University Hospital Zurich > Division of Psychiatric Research and Clinic for Psychogeriatric Medicine|
04 Faculty of Medicine > University Hospital Zurich > Institute of Experimental Immunology
|DDC:||570 Life sciences; biology|
610 Medicine & health
|Deposited On:||04 Jan 2010 18:33|
|Last Modified:||27 Nov 2013 20:12|
|Publisher:||Rockefeller University Press|
|Citations:||Web of Science®. Times Cited: 110|
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page